Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
European Neurology|January 1, 1981
Experimental approach of activity and mechanism(s) of action of drugs used in cerebral metabolic insufficiency. Application to 1-eburnamonineP Linee, M A Hollands, P Quiniou, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|June 1, 1983
[The HLA-DR determinants in chronic inflammatory rheumatism]G Chalès, R Fauchet, Y Pawlotsky, et al.
Presse Medicale (Paris, France : 1983)|December 3, 1983
[Relapse in Basedow's disease after treatment with synthetic antithyroid drugs. Prognostic value of analysis of the HLA system]H Allannic, R Fauchet, Y Lorcy, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1983
A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotypeH Allannic, R Fauchet, Y Lorcy, et al.
Gastroenterology|June 1, 1987
Porphyria cutanea tarda and HLA-linked hemochromatosis. Evidence against a systematic associationC Beaumont, R Fauchet, L N Phung, et al.
Diabete & Metabolisme|February 1, 1985
Factor B (Bf) and glyoxalase genes in insulin-dependent diabetes mellitusH Allannic, R Fauchet, M Gueguen, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|March 1, 1987
[B27-negative spondylarthritis. Results of 3 familial surveys, with monozygotic twins in one]G Chales, R Fauchet, M Gueguen, et al.
Clinical and Experimental Immunology|March 1, 1989
A new antigen recognized by anti-liver-kidney-microsome antibody (LKMA)P Codońer-Franch, K Paradis, M Gueguen, et al.
Annales D'Endocrinologie|January 1, 1980
[HLA DRW3 and Graves' disease (author's transl)]H Allannic, R Fauchet, Y Lorcy, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1980
HLA and Graves' disease: an association with HLA-DRw3H Allannic, R Fauchet, Y Lorcy, et al.
Pageof 5